IL-17A levels were similar in patients with and without HE (87.3 ± 264.7 vs. 100.3 ± 243.3 pg/mL; p = 0.835), ascites (96.4 ± 241.2 vs. 101.4 ± 250.3 pg/mL; p = 0.917), and renal failure (120.4 ± 251.6 vs. 93.3 ± 244.7 pg/mL; p = 0.523). This evidence concerns the gene IL17A and hereditary elliptocytosis.